行情

AVEO

AVEO

AVEO制药
NASDAQ

实时行情|Nasdaq Last Sale

8.47
-1.52
-15.21%
交易中 12:57 05/27 EDT
开盘
10.10
昨收
9.99
最高
10.32
最低
7.80
成交量
81.08万
成交额
--
52周最高
11.20
52周最低
2.230
市值
1.36亿
市盈率(TTM)
327.03
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AVEO价格均价为14.50,最高价位18.50,最低价为10.00。

EPS

AVEO 新闻

更多
58 Stocks Moving In Wednesday's Mid-Day Session
Gainers Hertz Global Holdings, Inc. (NYSE: HTZ) shares jumped 127% to $1.26. Hertz Global shares dipped over 80% on Tuesday after the company filed for Chapter 11 bankruptcy protection.
Benzinga · 38分钟前
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 118 companies set new 52-week highs.
Benzinga · 1天前
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Benzinga · 2天前
Stocks That Hit 52-Week Highs On Wednesday
During Wednesday's morning session, 85 stocks hit new 52-week highs.
Benzinga · 05/20 14:38
Stocks That Hit 52-Week Highs On Monday
During the morning session on Monday, 120 stocks hit new 52-week highs.
Benzinga · 05/18 14:44
Why You Shouldn't Bet Against AVEO Pharmaceuticals (AVEO) Stock
Zacks · 05/12 13:50
HC Wainwright & Co. Reiterates Buy on AVEO Pharmaceuticals, Raises Price Target to $10
HC Wainwright & Co. reiterates AVEO Pharmaceuticals (NASDAQ:AVEO) with a Buy and raises the price target from $6 to $10.
Benzinga · 05/01 11:12
Aveo Pharma up 40% after business update
AVEO Pharmaceuticals (AVEO +40.2%), fresh off a volatility halt, is up on a 15x surge in volume after its business update today. Key points: Final survival
seekingalpha · 04/30 20:45

所属板块

生物技术和医学研究
-1.08%
制药与医学研究
-0.81%

热门股票

代码
价格
涨跌幅

AVEO 简况

AVEO Pharmaceuticals, Inc.是一家生物制药公司。该公司的平台为癌症和相关疾病提供见解。该公司的候选产品包括Tivozanib、Ficlatuzumab、AV-203和AV-380。Tivozanib是一种选择性长半衰期血管内皮生长因子酪氨酸激酶抑制剂(VEGF TKI),用于抑制三种VEGF受体。Tivozanib用于优化VEGF阻断,同时最大限度降低脱靶毒性。Ficlatuzumab是一种肝细胞生长因子(HGF)抑制抗体。AV-203是一种具有ErbB3亲和力的抗ErbB3单克隆抗体。其临床前研究表明,神经调节基因1(NRG1)水平预测AV-203在临床前模型中的抗肿瘤活性。AV-380是一种人源免疫球蛋白G 1(IgG1)抑制性单克隆抗体。AV-380靶向生长分化因子15(GDF15)。
展开

微牛提供AVEO Pharmaceuticals, Inc.(NASDAQ-AVEO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AVEO股票新闻,以帮助您做出投资决策。